Tuesday, January 13, 2026 7:44:06 AM
🍿🇺🇸” PRESIDENT TRUMP’S EXECUTIVE ORDER DIRECTING HIS ATTORNEY GENERAL TO SWIFTLY RESCHEDULE CANNABIS TO SCHEDULE 111, COUPLED WITH THE 💥(FOOD AND DRUG ADMINISTRATION’S) PRIOR ANALYSIS RECOMMENDING RESCHEDULING, SHOULD BE A GAME CHANGER🚀 IN THE STATES THAT HAVE FAILED TO ADOPT MEDICAL CANNABIS LAWS,Karen O’ Keefe, state policy director at the Marijuana Policy Project (MPP), told Marijuana Moment. “Federal law is the brink of finally acknowledging cannabis has accepted medical use and that it is less risthan opioids.”
💥 https://www.marijuanamoment.net/which-states-most-likely-to-legalize-marijuana-in-2026/
💥 More GREAT NEWS for California based CV Sciences.
https://www.cannabis.ca.gov/posts/animal-cannabis-products-guidance/
💥 https://www.marijuanamoment.net/more-patients-sign-up-for-texas-medical-marijuana-program-as-new-dispensary-licenses-are-issued/
💥 https://link.springer.com/article/10.1186/s42238-025-00376-7
💥 https://www.marijuanamoment.net/which-states-most-likely-to-legalize-marijuana-in-2026/
💥 More GREAT NEWS for California based CV Sciences.
https://www.cannabis.ca.gov/posts/animal-cannabis-products-guidance/
💥 https://www.marijuanamoment.net/more-patients-sign-up-for-texas-medical-marijuana-program-as-new-dispensary-licenses-are-issued/
💥 https://link.springer.com/article/10.1186/s42238-025-00376-7
Bullish
Recent CVSI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:10:09 PM
- CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results • ACCESS Newswire • 05/14/2026 08:00:00 PM
- CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026 • ACCESS Newswire • 05/12/2026 10:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
